Synergy CHC Corp. Files S-1/A Amendment

TL;DR

Synergy CHC Corp. (formerly Synergy Strips) filed an S-1/A. SEC stuff.

AI Summary

Synergy CHC Corp. filed an S-1/A amendment on July 29, 2024, for its registration statement. The company, formerly known as Synergy Strips Corp. and Oro Capital Corporation, Inc., is incorporated in Nevada and operates in the medicinal chemicals & botanical products sector. Its principal executive office is located at 865 Spring Street, Westbrook, Maine.

Why It Matters

This filing indicates ongoing regulatory activity for Synergy CHC Corp., which could signal upcoming corporate actions or financial disclosures relevant to investors.

Risk Assessment

Risk Level: low — This is a routine S-1/A filing for a registration statement, not indicating immediate financial distress or significant new risks.

Key Numbers

• 2833 — SIC Code (Medicinal Chemicals & Botanical Products industry)
• 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year)

Key Players & Entities

• Synergy CHC Corp. (company) — Registrant
• Synergy Strips Corp. (company) — Former company name
• Oro Capital Corporation, Inc. (company) — Former company name
• Jack Ross (person) — Chief Executive Officer
• 0001013762-24-002165.txt (document) — Filing document identifier
• 333-280556 (registration_number) — SEC Registration Number

FAQ

Key Financial Figures

• $0.00001 — ; shares of our common stock, par value $0.00001 per share. We currently estimate that t
• $6.0 — y 2015 for cash consideration of $6.0 million, including earnout. In N
• $7.0 — D 10.0 million (or approximately $7.0 million), using a mix of cash an
• $42.8 — year ended December 31, 2023 was $42.8 million, an increase of $4.4&#x0
• $4.4 — as $42.8 million, an increase of $4.4 million, or 11%, over net revenu
• $9.4 — ;months ended March 31, 2024 was $9.4 million, an increase of $1.4&#x0
• $1.4 — was $9.4 million, an increase of $1.4 million, or 18.2% over net reven
• $6.4 million — expanded distribution, increasing from $6.4 million for the three months ended March 31, 20
• $8 — he three months ended March 31, 2023 to $8 million for the three mon
• $37.2 m — or the year ended December 31, 2023 was $37.2 million, a 17.0% increase over FOCUSfacto
• $31.8 million — for the year ended December 31, 2022 of $31.8 million. Following the completion of this offe
• $42.8 m — nues, net income (loss) and EBITDA were $42.8 million, $6.3 million and $10.8 million,
• $6.3 million — e (loss) and EBITDA were $42.8 million, $6.3 million and $10.8 million, respectively, as com
• $10.8 m — DA were $42.8 million, $6.3 million and $10.8 million, respectively, as compared to $38
• $38.4 m — 8 million, respectively, as compared to $38.4 million, $(32.6) million and $(25.8) mill

Filing Documents

• ea0208324-02.htm (S-1/A) — 5712KB
• ea020832402ex1-1_synergy.htm (EX-1.1) — 219KB
• ea020832402ex4-1_synergy.htm (EX-4.1) — 86KB
• ea020832402ex10-5_synergy.htm (EX-10.5) — 138KB
• ea020832402ex23-1_synergy.htm (EX-23.1) — 2KB
• tsynergy_001.jpg (GRAPHIC) — 75KB
• tpiechart_001.jpg (GRAPHIC) — 158KB
• 0001013762-24-002165.txt ( ) — 6480KB

RISK FACTORS

RISK FACTORS   11 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS   27

USE OF PROCEEDS

USE OF PROCEEDS   29 MARKET FOR OUR COMMON STOCK   30 DIVIDEND POLICY   30 CAPITALIZATION   31

DILUTION

DILUTION   32 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   34

BUSINESS

BUSINESS   46 MANAGEMENT   59 EXECUTIVE AND DIRECTOR COMPENSATION   65 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS   71 PRINCIPAL STOCKHOLDERS   73

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK   75 SHARES ELIGIBLE FOR FUTURE SALE   78 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS   79

UNDERWRITING

UNDERWRITING   83 LEGAL MATTERS   90 EXPERTS   90 WHERE YOU CAN FIND MORE INFORMATION   90 INDEX TO FINANCIAL STATEMENTS   F-1 You should rely only on the information contained in this prospectus or in any free writing prospectus that we may provide to you in connection with this offering. Neither we nor any of the underwriters has authorized anyone to provide you with information different from, or in addition to, that contained in this prospectus or in any such free writing prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. We can provide no assurance as to the reliability of any other information that others may give you. Neither we nor any of the underwriters is making an offer to sell or seeking offers to buy these securities in any jurisdiction where or to any person to whom the offer or sale is not permitted. The information in this prospectus is accurate only as of the date on the front cover of this prospectus, and the information in any free writing prospectus that we may provide you in connection with this offering is accurate only as of the date of such free writing prospectus. Our business, financial condition, results of operations and prospects may have changed since those dates. Trademarks We own or have rights to various trademarks, service marks and trade names that we use in connection with the operation of our business. This prospectus may also contain trademarks, service marks and trade names of third parties, which are the property of their respective owners. Our use or display of third parties’ trademarks, service marks and trade names or products in this prospectus is not intended to, and does not imply a relationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks, service marks and trade names referred to in this prospectus may appear without the ® , TM or SM symbols, but the

View Full Filing

View this S-1/A filing on SEC EDGAR